Neuralbase AI Ltd

Neuralbase AI Ltd. Stock Analysis VIRAD

United States N/A Nano Cap
Neuralbase AI Ltd. develops, markets and produces products to diagnose, screen, treat, heal, and improve the quality of life for cancer and viral patients.
Read More

Neuralbase AI Ltd (VIRAD) Chart

Key Statistics of Neuralbase AI Ltd (VIRAD)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$1.00$1.00

Today's Open

$1.00

Volume

-

P/E Ratio (TTM)

-

52 Week Range

$0.10$0.10

Market Cap

19.99K

Avg. Volume

-

Dividend Yield

-

Financial Metrics & Statements of Neuralbase AI Ltd (VIRAD)

FAQ's for Neuralbase AI Ltd (VIRAD)

  • According to Musaffa’s Shariah screening methodology, Neuralbase AI Ltd (VIRAD) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Disclaimer

The content provided on this website is intended solely for informational and educational purposes. Musaffa is a technology, data, education, and research company. We are not licensed financial service provider by the authorized relevant financial service regulator in India or any other regulatory government body, and we do not offer or facilitate any trading, brokerage, investment, or financial advisory services. We do not deliberately target an audience seeking financial services.

By accessing this website, you acknowledge and confirm that you are seeking information relating to Musaffa of your own accord, and that there has been no form of solicitation, advertisement, or inducement by Musaffa or its members. Musaffa shall not be liable for the consequences of any action taken by relying on the material or information provided on this website. The contents of this website are the intellectual property of Musaffa.